Skip to main content
Preventing Chronic Disease logoLink to Preventing Chronic Disease
letter
. 2008 Jun 15;5(3):A103.

Alzheimer’s Disease: A Major Challenge in the Effective Treatment of Depression in the Elderly

Shailendra Kapoor
PMCID: PMC2483545  PMID: 18558020

To the Editor:

The recent article by Snowden et al (1) is illuminating but does not mention the close relationship between late-life depression and Alzheimer's disease. Late-life depression may actually be an early manifestation of Alzheimer's disease itself. Failure to recognize subtle signs and symptoms can delay appropriate treatment, which is a major challenge in effectively treating depression in the elderly.

Rates of depression as high as 51% have been reported in patients with Alzheimer's disease (2). In fact, recent studies indicate that late-life depression may be a substantial risk factor for Alzheimer's disease (3). Wetherell et al have reported that elderly patients with depression are almost 4 times more likely than those without depression to develop Alzheimer's disease, and this risk is even greater in those patients who report symptoms such as decreased energy levels or a decline in interest (4). Patients with Alzheimer's disease who develop depression show decreased frontal lobe activity and glucose hypometabolism, especially in the bilateral superior gyri and the left anterior cingulated gyri (5).

Physicians should be aware of the close relationship between Alzheimer's disease and depression. Recognizing Alzheimer's disease and appropriately managing it can go a long way toward effectively treating late-life depression.

Footnotes

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the US Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above. URLs for nonfederal organizations are provided solely as a service to our users. URLs do not constitute an endorsement of any organization by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of Web pages found at these URLs.

Suggested citation for this article: Kapoor S. Alzheimer’s disease: a major challenge in the effective treatment of depression in the elderly [letter]. Prev Chronic Dis 2008;5(3). http://www.cdc.gov/pcd/issues/2008/jul/08_0005.htm. Accessed [date].

References

  • 1.Snowden M, Steinman L, Frederick J. Treating depression in older adults: challenges to implementing the recommendations of an expert panel. Prev Chronic Dis. 2008;5(1):A26. http://www.cdc.gov/pcd/issues/2008/jan/07_0154.htm . [PMC free article] [PubMed] [Google Scholar]
  • 2.Migliorelli R, Teson A, Sabe L, Petracchi M, Leiguarda R, Starkstein SE. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease. Am J Psychiatry. 1995;152(1):37–44. doi: 10.1176/ajp.152.1.37. [DOI] [PubMed] [Google Scholar]
  • 3.Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol. 2003;60(5):753–759. doi: 10.1001/archneur.60.5.753. [DOI] [PubMed] [Google Scholar]
  • 4.Wetherell JL, Gatz M, Johansson B, Pedersen NL. History of depression and other psychiatric illness as risk factors for Alzheimer disease in a twin sample. Alzheimer Dis Assoc Disord. 1999;13(1):47–52. doi: 10.1097/00002093-199903000-00007. [DOI] [PubMed] [Google Scholar]
  • 5.Hirono N, Mori E, Ishii K, Ikejiri Y, Imamura T, Shimomura T, et al. Frontal lobe hypometabolism and depression in Alzheimer's disease. Neurology. 1998;50(2):380–383. doi: 10.1212/wnl.50.2.380. [DOI] [PubMed] [Google Scholar]

Articles from Preventing Chronic Disease are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES